CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS

Ph.D

Saved in:
Bibliographic Details
Main Author: SEAH BEE KEE SERENA
Other Authors: NUS GRAD SCH FOR INTEGRATIVE SCI & ENGG
Format: Theses and Dissertations
Language:English
Published: 2013
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/37449
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-37449
record_format dspace
spelling sg-nus-scholar.10635-374492015-09-23T19:52:24Z CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS SEAH BEE KEE SERENA NUS GRAD SCH FOR INTEGRATIVE SCI & ENGG PERVAIZ, SHAZIB NSCLC, Cisplatin-resistance, TRAIL, Apoptosis Ph.D DOCTOR OF PHILOSOPHY 2013-04-12T18:00:22Z 2013-04-12T18:00:22Z 2012-09-28 Thesis SEAH BEE KEE SERENA (2012-09-28). CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS. ScholarBank@NUS Repository. http://scholarbank.nus.edu.sg/handle/10635/37449 NOT_IN_WOS en
institution National University of Singapore
building NUS Library
country Singapore
collection ScholarBank@NUS
language English
topic NSCLC, Cisplatin-resistance, TRAIL, Apoptosis
spellingShingle NSCLC, Cisplatin-resistance, TRAIL, Apoptosis
SEAH BEE KEE SERENA
CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS
description Ph.D
author2 NUS GRAD SCH FOR INTEGRATIVE SCI & ENGG
author_facet NUS GRAD SCH FOR INTEGRATIVE SCI & ENGG
SEAH BEE KEE SERENA
format Theses and Dissertations
author SEAH BEE KEE SERENA
author_sort SEAH BEE KEE SERENA
title CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS
title_short CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS
title_full CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS
title_fullStr CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS
title_full_unstemmed CHARACTERIZING CISPLATIN-RESISTANT NSCLC CELLS AND IDENTIFYING TRAIL AS A POTENTIAL SECOND-LINE THERAPY IN REFRACTORY CANCER CELLS
title_sort characterizing cisplatin-resistant nsclc cells and identifying trail as a potential second-line therapy in refractory cancer cells
publishDate 2013
url http://scholarbank.nus.edu.sg/handle/10635/37449
_version_ 1681081827480043520